Content Currently Unavailable
Article | 2026 American Glaucoma Society Meeting
Understanding FDA Pathways for MIGS
At AGS 2026, Douglas J. Rhee, MD, provided a practical overview of device regulation and its implications for MIGS adoption and reimbursement.
Content Currently Unavailable







